Stem Cell Therapy Market
Stem Cell Therapy Market Forecasts to 2028 - Global Analysis By Product (Human Embryonic Stem Cells (HESCs), Very Small Embryonic Like Stem Cells, Adult Stem Cells (ASCs) and Induced Pluripotent Stem Cells (iPSCs)), Therapy Type (Allogenic and Autologous), Technology (Expansion and Sub-Culture, Cell Production, Cryopreservation and Cell Acquisition), Application (Drug Discovery and Development and Regenerative Medicine), End User and By Geography
Years Covered |
2020-2028 |
Estimated Year Value (2022) |
US $257 MN |
Projected Year Value (2028) |
US $722.4 MN |
CAGR (2022 - 2028) |
18.8% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
North America |
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Stem Cell Therapy Market is accounted for $257 million in 2022 and is expected to reach $722.4 million by 2028 growing at a CAGR of 18.8% during the forecast period. Humans and animals both have stem cells, which are the most valuable cells in the body. Stem cells are cells that have the ability to proliferate and grow into practically any cell type in the body, and they are used in surgery and medicine. There are two types of stem cells: adult stem cells and embryonic stem cells. Embryonic stem cells are stem cells derived from human embryos (ESCs). They are pluripotent, which means they can develop into almost any type of cell in the body. Stem cell therapy is also known as regenerative medicine or centrepiece therapy. Regenerative medications have the ability to regenerate cells and replace those that have been damaged or perished.
According to estimates from the International Agency for Research on Cancer 2020, 1 in 5 people will develop cancer at some point in their lives, and 1 in 8 men and 1 in 11 women will pass away.
Market Dynamics:
Driver:
The rise in prevalence and incidence of chronic diseases
Chronic illnesses affect the vast majority of individuals worldwide. One in in three adults globally suffers from a chronic illness. Many people's health and quality of life have been negatively influenced by chronic diseases. Cancer, musculoskeletal and neurological problems, chronic injuries, cardiovascular and gastrointestinal conditions, and cancer can all lead to hospitalisation, long-term incapacity, a reduction in quality of life, and even death. Mesenchymal stem cells penetrate and integrate into various organs, treating lung, spinal cord, autoimmune illnesses, liver, bone, and cartilage diseases, and treating multiple organ damage. The use of stem cells in the treatment of inflammatory, immune system, and degenerative tissue diseases is a successful method.
Restraint:
Ethical concerns related to embryonic stem cells
Research into the therapeutic potential of embryonic stem cells (ESC) are linked to a number of ethical concerns related to the destruction of human embryos. In the future, a lack of clear federal policies defining what can be supported in embryo-based stem cell research or therapy development may limit market expansion to some extent. Furthermore, the complexities of legislation in this sector necessitate government guidelines that can assist researchers, scientists, and pharmaceutical companies in developing ESC therapy and facilitating its commercialization.
Opportunity:
Availability of funding for stem cell research
Stem cell research funding has increased in recent years, owing to the need for novel therapeutic approaches in patients with cardiovascular, neurological, and autoimmune illnesses. The NIH funding for stem cell research reached a new high in 2018, with a year-on-year increase of more than 5%. This trend is projected to continue with the increase in financing efforts planned in 2021. For example, in September 2021, the California Institute for Regenerative Medicine awarded Stanford Research a USD 31 million funding to launch first-in-human studies of stem cells in the treatment of heart failure, stroke, and spinal cord tumours.
Threat:
High cost of treatment
The high cost of cell therapy has limited market expansion. Cell therapies have developed as a prominent treatment option as people seek out the most recent therapy options. Despite the significant increase in demand, cell therapies remain too expensive to try. Simple joint injections can cost up to $1,000 depending on the situation, whereas more sophisticated surgeries might cost up to $100,000. The average cost of stem cell therapy in the United States is expected to be between $4,000 and $8,000 per patient in 2020. As a result, the high cost of treatment limits the expansion of the stem cell therapy market.
Covid-19 Impact
The COVID-19 pandemic had little effect on the stem cell therapy industry. The market saw a lot of activity because many research and government entities were focused on finding rapid and effective solutions to cure and prevent dangerous disorders like COVID-19. In fact, the pandemic provided the impetus needed to launch worldwide regenerative medicine clinical trials. Several clinical investigations have confirmed that MSC therapy could be a viable treatment option for COVID-19 patients, particularly those with acute respiratory distress syndrome.
The autologous segment is expected to be the largest during the forecast period
The autologous segment is estimated to have a lucrative growth, because of the increased usage of autologous stem cells and the availability of a variety of stem cell products. Recent advances in cellular technology have contributed to a better understanding of numerous disease cells and their metabolism at the molecular level, pushing the demand for stem cell therapies for treatment. Affordability, better patient survival rate, no need to identify an HLA-matched donor, and minimal risk of graft-versus-host disease are all expected to drive the expansion of this segment.
The cell acquisition segment is expected to have the highest CAGR during the forecast period
The cell acquisition segment is anticipated to witness the fastest CAGR growth during the forecast period. The discovery of embryonic stem cells has paved the path for the development of innovative treatments for a variety of ailments. These cells are pluripotent, which means they can be utilised to differentiate many different types of cells in the body. Obtaining embryonic cells directly from the embryo, on the other hand, has created ethical difficulties. As a result, researchers discovered an alternative—iPS cells. Cell acquisition is further subdivided into bone marrow harvest, umbilical blood cord harvest, and apheresis.
Region with highest share:
North America is projected to hold the largest market share during the forecast period, because of the robust biotechnology industry, the domination of major key firms, considerable R&D efforts, and the promotion of individualised medications. Furthermore, this sector's rise can be attributable to a growing government initiative to promote stem cell therapy. For example, in March 2020, the Canadian government invested around USD 7 million towards regenerative medicine and stem cell research. It will support the country's expansion in the regenerative medicine sector by funding nine transnational initiatives and four clinical trials.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, because of the development of stem cell-based medicines, government initiatives for producing regenerative drugs, the establishment of multiple stem cell banks, and the region's growing clinical studies for genetic engineering and biomedical research. For example, the government of India has established cutting-edge stem cell research facilities in 40 top health research and educational institutes by February 2022.
Key players in the market
Some of the key players profiled in the Stem Cell Therapy Market include CORESTEM, Regrow Biosciences Pvt Ltd., Takeda Pharmaceutical Company Limited, MEDIPOST Co., Ltd., Orthofix Holdings, Inc., Smith & Nephew plc, Novadip Biosciences, Fujifilm Holding Corporation, Astellas Pharma Inc., Allele Biotechnology and Pharmaceuticals, Inc., NuVasive, Inc., Mesoblast Ltd., Anterogen.Co., Ltd.,JCR Pharmaceuticals Co., Ltd. and AlloSource.
Key Developments:
In July 2022, CORESTEM (South Korea) continued enrolling participants for the Phase 3 clinical trial of NeuroNata-R. This therapy has received conditional approval for treating ALS patients in South Korea.
Products Covered:
• Human Embryonic Stem Cells (HESCs)
• Very Small Embryonic Like Stem Cells
• Adult Stem Cells (ASCs)
• Induced Pluripotent Stem Cells (iPSCs)
Therapy Types Covered:
• Allogenic
• Autologous
Technologies Covered:
• Expansion and Sub-Culture
• Cell Production
• Cryopreservation
• Cell Acquisition
Applications Covered:
• Drug Discovery and Development
• Regenerative Medicine
End Users Covered:
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Cell Banks
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Stem Cell Therapy Market, By Product
5.1 Introduction
5.2 Human Embryonic Stem Cells (HESCs)
5.3 Very Small Embryonic Like Stem Cells
5.4 Adult Stem Cells (ASCs)
5.4.1 Epithelial/Skin
5.4.2 Hematopoietic
5.4.3 Neural
5.4.4 Mesenchymal
5.4.5 Other Adult Stem Cells (ASCs)
5.5 Induced Pluripotent Stem Cells (iPSCs)
6 Global Stem Cell Therapy Market, By Therapy Type
6.1 Introduction
6.2 Allogenic
6.3 Autologous
7 Global Stem Cell Therapy Market, By Technology
7.1 Introduction
7.2 Expansion and Sub-Culture
7.3 Cell Production
7.3.1 Cell Culture
7.3.2 In-vitro Fertilization
7.3.3 Isolation
7.3.4 Therapeutic Cloning
7.4 Cryopreservation
7.5 Cell Acquisition
7.5.1 Apheresis
7.5.2 Bone Marrow Harvest
7.5.3 Umbilical Blood Cord
8 Global Stem Cell Therapy Market, By Application
8.1 Introduction
8.2 Drug Discovery and Development
Regenerative Medicine
8.3.1 Diabetes
8.3.2 Incontinence
8.3.3 Oncology
8.3.4 Cardiovascular and Myocardial Infraction
8.3.5 Neurology
8.3.6 Injuries
8.3.7 Orthopedics
8.3.8 Liver Disorder
8.3.9 Hematology
8.3.10 Other Regenerative Medicines
9 Global Stem Cell Therapy Market, By End User
9.1 Introduction
9.2 Academic & Research Institutes
9.3 Pharmaceutical & Biotechnology Companies
9.4 Hospitals & Cell Banks
10 Global Stem Cell Therapy Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 CORESTEM
12.2 Regrow Biosciences Pvt Ltd.
12.3 Takeda Pharmaceutical Company Limited
12.4 MEDIPOST Co., Ltd.
12.5 Orthofix Holdings, Inc.
12.6 Smith & Nephew plc
12.7 Novadip Biosciences
12.8 Fujifilm Holding Corporation
12.9 Astellas Pharma Inc.
12.10 Allele Biotechnology and Pharmaceuticals, Inc.
12.11 NuVasive, Inc.
12.12 Mesoblast Ltd.
12.13 Anterogen.Co., Ltd.
12.14 JCR Pharmaceuticals Co., Ltd.
12.15 AlloSource
List of Tables
1 Global Stem Cell Therapy Market Outlook, By Region (2020-2028) ($MN)
2 Global Stem Cell Therapy Market Outlook, By Product (2020-2028) ($MN)
3 Global Stem Cell Therapy Market Outlook, By Human Embryonic Stem Cells (HESCs) (2020-2028) ($MN)
4 Global Stem Cell Therapy Market Outlook, By Very Small Embryonic Like Stem Cells (2020-2028) ($MN)
5 Global Stem Cell Therapy Market Outlook, By Adult Stem Cells (ASCs) (2020-2028) ($MN)
6 Global Stem Cell Therapy Market Outlook, By Epithelial/Skin (2020-2028) ($MN)
7 Global Stem Cell Therapy Market Outlook, By Hematopoietic (2020-2028) ($MN)
8 Global Stem Cell Therapy Market Outlook, By Neural (2020-2028) ($MN)
9 Global Stem Cell Therapy Market Outlook, By Mesenchymal (2020-2028) ($MN)
10 Global Stem Cell Therapy Market Outlook, By Other Adult Stem Cells (ASCs) (2020-2028) ($MN)
11 Global Stem Cell Therapy Market Outlook, By Induced Pluripotent Stem Cells (iPSCs) (2020-2028) ($MN)
12 Global Stem Cell Therapy Market Outlook, By Therapy Type (2020-2028) ($MN)
13 Global Stem Cell Therapy Market Outlook, By Allogenic (2020-2028) ($MN)
14 Global Stem Cell Therapy Market Outlook, By Autologous (2020-2028) ($MN)
15 Global Stem Cell Therapy Market Outlook, By Technology (2020-2028) ($MN)
16 Global Stem Cell Therapy Market Outlook, By Expansion and Sub-Culture (2020-2028) ($MN)
17 Global Stem Cell Therapy Market Outlook, By Cell Production (2020-2028) ($MN)
18 Global Stem Cell Therapy Market Outlook, By Cell Culture (2020-2028) ($MN)
19 Global Stem Cell Therapy Market Outlook, By In-vitro Fertilization (2020-2028) ($MN)
20 Global Stem Cell Therapy Market Outlook, By Isolation (2020-2028) ($MN)
21 Global Stem Cell Therapy Market Outlook, By Therapeutic Cloning (2020-2028) ($MN)
22 Global Stem Cell Therapy Market Outlook, By Cryopreservation (2020-2028) ($MN)
23 Global Stem Cell Therapy Market Outlook, By Cell Acquisition (2020-2028) ($MN)
24 Global Stem Cell Therapy Market Outlook, By Apheresis (2020-2028) ($MN)
25 Global Stem Cell Therapy Market Outlook, By Bone Marrow Harvest (2020-2028) ($MN)
26 Global Stem Cell Therapy Market Outlook, By Umbilical Blood Cord (2020-2028) ($MN)
27 Global Stem Cell Therapy Market Outlook, By Application (2020-2028) ($MN)
28 Global Stem Cell Therapy Market Outlook, By Drug Discovery and Development (2020-2028) ($MN)
29 Global Stem Cell Therapy Market Outlook, By Regenerative Medicine (2020-2028) ($MN)
30 Global Stem Cell Therapy Market Outlook, By Diabetes (2020-2028) ($MN)
31 Global Stem Cell Therapy Market Outlook, By Incontinence (2020-2028) ($MN)
32 Global Stem Cell Therapy Market Outlook, By Oncology (2020-2028) ($MN)
33 Global Stem Cell Therapy Market Outlook, By Cardiovascular and Myocardial Infraction (2020-2028) ($MN)
34 Global Stem Cell Therapy Market Outlook, By Neurology (2020-2028) ($MN)
35 Global Stem Cell Therapy Market Outlook, By Injuries (2020-2028) ($MN)
36 Global Stem Cell Therapy Market Outlook, By Orthopedics (2020-2028) ($MN)
37 Global Stem Cell Therapy Market Outlook, By Liver Disorder (2020-2028) ($MN)
38 Global Stem Cell Therapy Market Outlook, By Hematology (2020-2028) ($MN)
39 Global Stem Cell Therapy Market Outlook, By Other Regenerative Medicines (2020-2028) ($MN)
40 Global Stem Cell Therapy Market Outlook, By End User (2020-2028) ($MN)
41 Global Stem Cell Therapy Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
42 Global Stem Cell Therapy Market Outlook, By Pharmaceutical & Biotechnology Companies (2020-2028) ($MN)
43 Global Stem Cell Therapy Market Outlook, By Hospitals & Cell Banks (2020-2028) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.